Effect of muscle relaxation and its reversal on the control of breathing

Phase 1

• Conditions: Postoperative ventilatory control; MedDRA version: 19.0Level: LLTClassification code 10038680Term: Respiratory depression postoperSystem Organ Class: 100000004855; Therapeutic area: Not possible to specify

• Registration Number: EUCTR2015-005222-19-NL
• Lead Sponsor: eiden University Medical Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-07-13
• Last Update Posted: 8 August 2016

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Healthy male volunteers aged 18 and older with a body mass index < 30 kg/m2.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 36
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Known or suspected neuromuscular disorders impairing neuromuscular function; allergies to muscle relaxants, anesthetics or narcotics; a (family) history of malignant hyperthermia or any other muscle disease; any medical, neurological or psychiatric illness (including a history of anxiety).

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified